Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patients
about
Pharmacogenomics: personalizing pediatric heart transplantationPopulation pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome.Population pharmacokinetic-pharmacodynamic modelling of mycophenolic acid in paediatric renal transplant recipients in the early post-transplant periodUGT1A9, UGT2B7, and MRP2 genotypes can predict mycophenolic acid pharmacokinetic variability in pediatric kidney transplant recipientsPaediatric use of mycophenolate mofetil.Pharmacogenetics and individualized therapy in children: immunosuppressants, antidepressants, anticancer and anti-inflammatory drugs.Optimization of pediatric rheumatology therapeutics.Ontogeny of oral drug absorption processes in children.Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease.Pharmacogenetics of drugs used in the treatment of ocular inflammatory diseases.How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.Dosing algorithms for initiation of immunosuppressive drugs in solid organ transplant recipients.Steady-state pharmacokinetics of mycophenolic acid in renal transplant patients: exploratory analysis of the effects of cyclosporine, recipients' and donors' ABCC2 gene variants, and their interactions.What is the intrapatient variability of mycophenolic acid trough levels?Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacrolimus in pediatric and adolescent kidney transplant recipients.Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype.Developmental changes of MPA exposure in children.Mycophenolate mofetil for steroid-dependent nephrotic syndrome: a phase II Bayesian trial.Pharmacokinetics and target attainment of mycophenolate in pediatric renal transplant patients.
P2860
Q28081200-A01170A4-01BD-4AFB-94F2-3E7F6D8CFD2FQ33764995-823B2FC1-C11E-4D09-9364-E698E0A57EEFQ34570937-0B39B7B4-1F60-424B-BEE5-83169AB27BA0Q36400272-37002E6C-518D-4223-8DF9-8574F755AA3FQ36562448-348EAAAF-E093-4735-9510-AE7AE4C77872Q37892531-0078F47A-2C71-44E4-BD0C-7C097C3A2AFDQ37991520-DBECD4DE-BF16-48CC-B247-693E768E11B5Q38017723-BF864D74-7339-439A-BA14-D07003B1838EQ38087925-CFF2788B-2F3B-4D48-997E-76E320A8B518Q38092131-48528E53-FF2D-43FB-A35A-1DEC4973E98DQ38170321-9849080E-9999-4621-A3EC-B5864419BC9CQ38208983-D022E7A8-3E35-4CF5-8A2B-EEBF21A04E92Q38417581-6E2AA6C5-2CC6-4E72-A855-513F3C7A1F84Q38720831-40EDFA75-8346-4626-9A2C-4F0C6D941B7DQ40707992-AE98CDB4-04C2-442C-B59A-27A011C2F873Q43570020-D4EC5BFA-A15D-45F7-B00E-0333E6E78526Q48175100-29743D08-3BBB-4F96-B811-66CD3CE8E9E7Q50541249-DB1898B6-04D5-48D0-B16D-7D593EC09DDDQ51529212-C06B3031-A80A-4578-B52F-68B7565C3AC9Q53163992-D296688F-1D9B-4AE9-9870-FE7B191A233A
P2860
Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patients
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Population pharmacokinetics an ...... tric renal-transplant patients
@ast
Population pharmacokinetics an ...... tric renal-transplant patients
@en
Population pharmacokinetics an ...... tric renal-transplant patients
@nl
type
label
Population pharmacokinetics an ...... tric renal-transplant patients
@ast
Population pharmacokinetics an ...... tric renal-transplant patients
@en
Population pharmacokinetics an ...... tric renal-transplant patients
@nl
prefLabel
Population pharmacokinetics an ...... tric renal-transplant patients
@ast
Population pharmacokinetics an ...... tric renal-transplant patients
@en
Population pharmacokinetics an ...... tric renal-transplant patients
@nl
P2093
P2860
P50
P356
P1476
Population pharmacokinetics an ...... tric renal-transplant patients
@en
P2093
Albert Bensman
Georges Deschênes
Gwenaelle Roussey
Jean Luc André
Karine Brochard
May Fakhoury
Patrick Niaudet
Pierre Cochat
Saïd Azougagh
Sylvie Cloarec
P2860
P304
P356
10.1177/0091270009357429
P407
P577
2010-11-01T00:00:00Z